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Yearbyyear,thecharacterizationofthebiologicalactivityofnaturalproductsisbecomingmorecompetitiveandcomplex,withthe
involvement in this research area of experts belonging to diﬀerent scientiﬁc ﬁelds, including chemistry, biochemistry, molecular
biology, immunology and bioinformatics. These ﬁelds are becoming of great interest for several high-impact scientiﬁc journals,
including eCAM. The available literature in general, and a survey of reviews and original articles recently published, establishes
thatnaturalproducts,includingextractsfrommedicinalplantsandessentialoils,retaininterestingtherapeuticactivities,including
antitumor, antiviral, anti-inﬂammatory, pro-apoptotic and diﬀerentiating properties. In this commentary, we focus attention on
interest in networks based on complementary activation and comparative evaluation of diﬀerent experimental strategies applied
to the discovery and characterization of bioactive natural products. A representative ﬂow chart is shown in the paper.
1.PlantExtractsExhibitBiological
Properties Relevant for Alternative
Treatments of Human Diseases
A ﬁrst level of screening that is followed by many research
groups allows the identiﬁcation of plant extracts and essen-
tial oils exhibiting relevant biomedical eﬀects (action I of
the ﬂow chart shown in Figure 1)[ 1–8]. A careful review
of the conclusions in available literature reveals that several
plant extracts exhibit activity against herpes simplex virus
[4]. On the other hand, several plant extracts stimulate
expression of diﬀerentiation-related functions of great value
for developing drugs against important genetic diseases [9].
A complementary approach focusing on mechanism(s)
of action instead of bio-medical eﬀects identiﬁes possible
molecular targets of plant extracts (action II of Figure 1).
Lampronti et al. [10] were able to demonstrate that extracts
from medicinal plants diﬀerentially inhibit molecular inter-
actions between nuclear factor κB( N F - κB) and target DNA.
The ﬁnding of activity against a transcription factor (TF)
stimulated experiments on eﬀects of single plant extracts or
essential oils on biological functions depending on this TF.
NF-κB is deeply involved in inﬂammatory processes, as well
as antiapoptotic properties. Hence, plant extracts inhibiting
NF-κB (for instance, extracts from Emblica oﬃcinalis)d e e p l y
modify the production of inﬂammation-related proteins
induced in bronchial cell lines by Pseudomona aeruginosa
(PAO) infection [11]. Nicolis et al. [11] demonstrated that
extracts from E. oﬃcinalis strongly inhibited the PAO-
dependent expression of the neutrophil chemokines IL-8,
GRO-α and GRO-γ, of the Inter-Cellular Adhesion Molecule
1 (ICAM-1) and of the pro-inﬂammatory cytokine IL-
6, when tested in human IB3-1 bronchial epithelial cells
exposed to the P. aeruginosa laboratory strain PAO1. This
ﬁnding might be relevant for treatment of the inﬂammatory
process of cystic ﬁbrosis (CF) [12]. In fact, the most
important cause of morbidity and mortality in CF patients
is the lung pathology characterized by chronic infection and
inﬂammation sustained mainly by P. aeruginosa.
Penolazzi et al. [13] demonstrated that E. oﬃcinalis
extracts induce apoptosis of primary osteoclasts (OCs), as a
possible treatment of osteoporosis and rheumatoid arthritis.
In this study, the eﬀects of extracts from E. oﬃcinalis
on diﬀerentiation and survival of human primary OC
cultures obtained from peripheral blood were determined
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colorimetric studies based on 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay. The eﬀects
of E. oﬃcinalis extracts on induction of OC apoptosis
were studied using the terminal dUTP nick-end labeling
(TUNEL) assay and immunocytochemical analysis of Fas
receptor expression. Extracts of E. oﬃcinalis were able to
induce programmed cell death of mature OCs, without
altering the process of osteoclastogenesis. Emblica oﬃcinalis
increased the expression levels of Fas, a critical member
of the apoptotic pathway. Interestingly, the extracts of E.
oﬃcinalis inhibited in both the cellular systems described
by Nicolis et al. [11] and by Penolazzi et al. [13] the
expressionofthepro-inﬂammatoryIL-6genewhenanalyzed
by reverse transcriptase-polymerase chain reaction (RT–
PCR) and immunocytochemistry.
Eﬀects of plant extracts on cytokines have been recently
published in eCAM by Zhao et al. [14], Saad et al. [15]a n d
Park et al. [16]. The use of botanicals in osteoarthritis and
rheumatoid arthritis has also been proposed by Ahmed et al.
[17].
2. Looking for Lead Compounds within
PlantExtracts
After the formal demonstration of a relevant biological
activity, including possible eﬀects on speciﬁc molecular
targets, two complementary approaches can be followed for
identiﬁcation of putative lead compounds. The ﬁrst (action
IV of Figure 1) is a direct chemical analysis of plant extracts,
based on several methods such as gas chromatography/mass
spectrometry (GC-MS) and high-performance liquid chro-
matography/MS (HPLC-MS). The second (action III of
Figure 1) is an activity of data mining focusing on what is
available in the literature concerning bioactive plant extracts.
Both these approaches can generate sets of molecules that
are possibly responsible for biological activity found in
analyzedextracts(actionsV-aandV-bofFigure 1).Thisisan
importantprocessthatwillultimatelyhelpinidentifyinglead
compounds to be employed in preclinical studies. Examples
of this process are those reported by Nicolis et al. [11]w h o
identiﬁedpyrogallolasthebioactivemoleculewithinextracts
of E. oﬃcinalis that inhibit IL-8 gene expression.
More recently, Guerrini et al. [18] have found that
citropten and bergapten, detected in epicarps of Citrus
bergamia fruits, are powerful inducers of diﬀerentiation and
γ-globin gene expression in human erythroid cells. These
data could have practical relevance, since pharmacologically
mediated regulation of human γ-globin gene expression,
with the consequent induction of fetal hemoglobin, is con-
sidered as a potential therapeutic approach in hematological
disorders, including β-thalassemia and sickle cell anemia [9].
3.Identiﬁcation of Molecular Targets and
Studiesof StructurallyRelatedCompounds
Collaboration between chemists, molecular and cellular
biologists is of great added value. The identiﬁcation of
putative molecular targets is important for at least two
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Figure 1: The interplay between several actions contributing to
the characterization of biological activity of natural products from
plant extracts. Numbering (I–VIII) facilitates the presentation
of the diﬀerent activities leading to the ﬁnal identiﬁcation of
bioactive compounds starting from plant extracts, through inter-
mediateproducts(databasesfrombioactiveplantextracts,chemical
libraries).
reasons: (i) development of advanced biological assays and
(ii) screening of sets of structurally related compounds.
Several research groups have hypothesized speciﬁc cellular
targets for lead compounds identiﬁed in medicinal plant
extracts. For instance, Dat et al. [19] identiﬁed the phenolic
constituents of Amorpha fruticosa that inhibit NF-κBa c t i v a -
tion and related gene expression. When the identiﬁcation of
a molecular target is available, then novel approaches might
be undertaken to characterize both mechanisms of action,
binding modes and novel bioactive molecules (actions VI–
VIII of Figure 1). Piccagli et al. [20]r e c e n t l yr e p o r t e da
docking study to NF-κB-p50 on a data set of 27 molecules
from extracts of two diﬀerent medicinal plants. The purpose
of the study was to develop a docking protocol ﬁt for the
target under study [20]. They enhanced the simple docking
procedurebymeansofasortofcombinedtarget-andligand-
based drug design approach. The results sustain the concept
that docking performance is predictive of a biochemical
activity. Through molecular docking simulations, this article
represents an example of successful indentiﬁcation, starting
from a set of molecules found in plant extracts, of a lead
compoundpromisingforinhibitionofNF-κB-p50biological
activity and modulation of expression of NF-κB-regulated
genes (in this case the IL-8 gene) [20]. Similar computer-
based strategies have been recently applied to other natural
products, looking for eﬀects on diﬀerent biological functions
by Rollinger et al. [21]o nRuta graveolens extracts, by Chen
et al. [22] on suanzaroen decotion and by Paoletta et al.
[23] using a data set from 240 herbs used in traditional
Chinese medicine. These recent studies support the concept
that computer-assisted approaches, such as pharmacophore
modeling, virtual screening, docking and neural networking
will help in identifying bioactive metabolites in extractsEvidence-Based Complementary and Alternative Medicine 3
from medicinal plants [24]. Integrated computer-assisted
strategies may help to process the huge amount of available
structural and biological information in a reasonably short
time for a straightforward search of bioactive natural prod-
ucts(actionV-coftheﬂowchartshowninFigure 1)[24,25].
4. FinalComments
Analyzing biological activity of plant extracts is rapidly
moving from simple observations to integrated research
approaches involving analytical chemistry, chemical syn-
thesis, molecular and cellular biology, proteomics, tran-
scriptomics and bioinformatics. The comparative analysis
of complementary studies will bring novel information
on bioactive compounds from natural products, including
molecular targets and putative mechanisms of action. In
particular, in silico tools, combined with classical research
methods, are expected to be more frequently applied by
natural product scientists in an eﬀort to maximize eﬃcacy in
drug discovery. These multidisciplinary studies are expected
to bring novel molecules of great biomedical relevance. The
journal eCAM is deeply involved in bringing to the scientiﬁc
community high-level relevant communications.
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